MedPath
HSA Approval

INOSERT 50 TABLET 50mg

SIN14790P

INOSERT 50 TABLET 50mg

INOSERT 50 TABLET 50mg

May 26, 2015

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N06AB06

sertraline

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

Ipca Laboratories Limited

Active Ingredients

SERTRALINE HYDROCHLORIDE 55.95 mg EQV SERTRALINE

50 mg

Sertraline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

INOSERT 50 TABLET 50mg - HSA Approval | MedPath